# Anesthetics to Prevent Lung Injury in Cardiac Surgery

> **NCT02918877** · PHASE1,PHASE2 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 51 (actual)

## Conditions studied

- Inflammatory Lung Injury
- Ischemia-Reperfusion Lung Injury
- Postoperative Pulmonary Complications

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT02918877
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-09
- **Primary completion:** 2018-12-24
- **Final completion:** 2021-02-01
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2021-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02918877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02918877, "Anesthetics to Prevent Lung Injury in Cardiac Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02918877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*